SubHero Banner

Novo Nordisk – Shortage of Wegovy® (semaglutide)

OptumRx has learned of a supply disruption of Novo Nordisk’s Wegovy (semaglutide) 0.25 mg, 0.5 mg and 1 mg strengths until the 2nd half of 2022 due to manufacturing delays. The 1.7 mg and 2.4 mg dose strengths are expected to experience minimal disruption.

Download PDF